Welcome to visit Zhongnan Medical Journal Press Series journal website!
Zhongnan Medical Journal Press
Series of Journals
Center for Evidence-Based and Translational Medicine of Wuhan University
The title
The title
The keywords
The author
Submit
Home
About us
Journal Introduction
Chief Editor
Editorial Committee
Author Center
Submission Guide
Assignment Agreement
Articles
Subscribe
Copyright
Contact us
Draft submission system
Author login
Author register
Reviewer login
Editor login
Home
Results
The title
The title
The keywords
The author
A total of
21
result was found. Results that relate to
Tumor
龙血竭化学成分与药理作用研究进展
YAN Xiaorui
ZHAO Xiangxuan
DOI:10.12173/j.issn.2097-4922.202505024
Dragon's blood
Natural compounds
Anti-inflammatory and analgesic
Anti-platelet aggregation
Neuroprotection
Anti-
tumor
Details
Download
Mobile
仙鹤草的抗肿瘤活性作用机制与临床应用研究进展
CHENG Gang
TAO Xuegang
CHEN Guilin
HE Zhongjing
ZHANG Huani
LIU Fulin
YIN Li
DOI:10.12173/j.issn.2097-4922.202506003
Agrimoniae herba
Anti-
tumor
Active ingredients
Mechanism of action
Clinical application
Details
Download
Mobile
中药活性成分逆转肿瘤多药耐药及协同增效作用的研究进展
CHENG Bing
SONG Min
XU Lingxia
DOI:10.12173/j.issn.2097-4922.202506032
Tumor
multidrug resistance
Active components of traditional Chinese medicine
Synergistic effect
Molecular mechanism
Details
Download
Mobile
基于FAERS的地舒单抗联合维生素D不良反应信号分析
SHEN Yang
CHEN Jihang
DOI:10.12173/j.issn.2097-4922.202507083
Denosumab
Vitamin D
FAERS database
Adverse drug events
Osteoporosis
Signal mining
Off-label use
Benign giant cell
tumor
of bone
Myalgia
Details
Download
Mobile
结合FAERS数据库和网络毒理学对奥曲肽不良事件和毒理学机制的有效分析
WANG Changwen
WANG Huiru
XU Shibo
SUN Fanfan
YAN Junzhen
DOI:10.12173/j.issn.2097-4922.202504044
Octreotide
Adverse drug events
Network toxicology
Signal mining
FAERS
Tumor
necrosis factor
Ransforming growth factor β
Protein-protein interaction
Details
Download
Mobile
国际抗肿瘤药物剂量舍入研究对我国抗肿瘤药物成本影响分析
REN Lingzhi
YU Wenhao
WANG Ting
TANG Min
ZHOU Ziyuan
TANG Haochun
MENG Jun
DOI:10.12173/j.issn.2097-4922.202504050
Anti-
tumor
drugs
Dose rounding
Drug cost
Cost saving
Healthcare expenses
Economic burden
Monoclonal antibody
Details
Download
Mobile
上一页
1
2